0
Clinical Investigations: ASTHMA |

Bronchoprotective Effects of Single Doses of Salmeterol Combined With Montelukast in Thermally Induced Bronchospasm*

Albert Coreno, MS, MBA; Mary Skowronski, MEd; Erin West, BS; Amr El-Ekiaby, MD; E.R. McFadden, Jr, MD
Author and Funding Information

From the Center for Academic Clinical Research, Case Western Reserve University School of Medicine, and the Division of Pulmonary Critical Care and Sleep Medicine and Department of Medicine of MetroHealth Medical Center, Cleveland, OH.

Correspondence to: E.R. McFadden, Jr., MD, Division of Pulmonary, Critical Care, and Sleep Medicine, MetroHealth Medical Center, 2500 MetroHealth Drive, Cleveland, OH 44109; e-mail: erm2@cwru.edu



Chest. 2005;127(5):1572-1578. doi:10.1378/chest.127.5.1572
Text Size: A A A
Published online

Study objectives: Salmeterol (S) and montelukast (M) individually inhibit the obstructive consequences of thermal stimuli such as exercise and hyperventilation (HV), but there is no information on whether these drugs can interact positively.

Design: Randomized trial.

Setting: University teaching hospital.

Participants: Atopic asthmatic patients with sensitivity to thermal provocations.

Interventions: Eleven asthmatic patients generated stimulus-response curves to isocapnic HV while breathing frigid air without any interventions and then after pretreatment with 42 μg of S, 10 mg of M, and the combination. The order of testing was randomly determined.

Measurements and results: Minute ventilation (V̇e) was increased in 20-L increments until FEV1 fell ≥ 15%. Measurements were obtained before and 1 h after drug administration, and then again 5 min after each bout of HV. In the nonintervention trial, the provocation commenced after the patients presented to the laboratory. In the control challenge, the mean (± SEM) FEV1 decreased 24.6 ± 1.7% from baseline. S and M both increased the mean prechallenge FEV1 significantly (S, 10.4 ± 1.7% [p < 0.01]; M, 4.1 ± 1.3% [p = 0.02]; S + M, p = 0.01). The combination of S + M produced greater bronchodilatation (mean improvement, 12.4 ± 2.3%) than M alone (p = 0.004), but not greater than S alone (p = 0.80). Both drugs blunted the obstructive response similarly (protection: M, 34.6 ± 15.1%; S, 60 ± 8.7%; p = 0.13). The benefits added arithmetically with the combined regimen (protection with S + M, 84.9 ± 5.5%; p = 0.01 vs S alone; p = 0.003 vs M alone).

Conclusion: These data indicate that the concurrent administration of single standard doses of S and M appears to provide greater protection against thermal stimuli than does either drug alone. Further experimentation will be required to ascertain whether the combination will provide additional clinical benefits to patients over those of the single agents.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Drugs for asthma. Med Lett Drugs Ther 1999;41(1044):5-10.
Drugs for asthma. Med Lett Drugs Ther 2000;42(1073):19-24.
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543